These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Nonalcoholic Steatohepatitis: A Search for Factual Animal Models. Sanches SC; Ramalho LN; Augusto MJ; da Silva DM; Ramalho FS Biomed Res Int; 2015; 2015():574832. PubMed ID: 26064924 [TBL] [Abstract][Full Text] [Related]
27. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time. Sellmann C; Priebs J; Landmann M; Degen C; Engstler AJ; Jin CJ; Gärttner S; Spruss A; Huber O; Bergheim I J Nutr Biochem; 2015 Nov; 26(11):1183-92. PubMed ID: 26168700 [TBL] [Abstract][Full Text] [Related]
29. Comprehensive Study of Multiple Stages Progressing to Nonalcoholic Steatohepatitis with Subsequent Fibrosis in SD Rats. Wang L; Wu S; Cai M; Ma J; Li S; Li M; Xu Y; Wei L; Shang J Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28820447 [TBL] [Abstract][Full Text] [Related]
30. Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients. Teufel A; Itzel T; Erhart W; Brosch M; Wang XY; Kim YO; von Schönfels W; Herrmann A; Brückner S; Stickel F; Dufour JF; Chavakis T; Hellerbrand C; Spang R; Maass T; Becker T; Schreiber S; Schafmayer C; Schuppan D; Hampe J Gastroenterology; 2016 Sep; 151(3):513-525.e0. PubMed ID: 27318147 [TBL] [Abstract][Full Text] [Related]
31. Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease. Li DJ; Liu J; Hua X; Fu H; Huang F; Fei YB; Lu WJ; Shen FM; Wang P Metabolism; 2018 Feb; 79():52-63. PubMed ID: 29129819 [TBL] [Abstract][Full Text] [Related]
32. Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography. Imajo K; Kessoku T; Honda Y; Tomeno W; Ogawa Y; Mawatari H; Fujita K; Yoneda M; Taguri M; Hyogo H; Sumida Y; Ono M; Eguchi Y; Inoue T; Yamanaka T; Wada K; Saito S; Nakajima A Gastroenterology; 2016 Mar; 150(3):626-637.e7. PubMed ID: 26677985 [TBL] [Abstract][Full Text] [Related]
33. Characterization of hepatic lipid profiles in a mouse model with nonalcoholic steatohepatitis and subsequent fibrosis. Saito K; Uebanso T; Maekawa K; Ishikawa M; Taguchi R; Nammo T; Nishimaki-Mogami T; Udagawa H; Fujii M; Shibazaki Y; Yoneyama H; Yasuda K; Saito Y Sci Rep; 2015 Aug; 5():12466. PubMed ID: 26289793 [TBL] [Abstract][Full Text] [Related]
34. Does fructose consumption contribute to non-alcoholic fatty liver disease? Tappy L; Lê KA Clin Res Hepatol Gastroenterol; 2012 Dec; 36(6):554-60. PubMed ID: 22795319 [TBL] [Abstract][Full Text] [Related]
35. Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress. Li BH; He FP; Yang X; Chen YW; Fan JG Transl Res; 2017 Feb; 180():103-117.e4. PubMed ID: 27639593 [TBL] [Abstract][Full Text] [Related]
36. Liver zonation in children with non-alcoholic fatty liver disease: Associations with dietary fructose and uric acid concentrations. Nobili V; Mosca A; De Vito R; Raponi M; Scorletti E; Byrne CD Liver Int; 2018 Jun; 38(6):1102-1109. PubMed ID: 29222961 [TBL] [Abstract][Full Text] [Related]
37. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis. Bellanti F; Villani R; Facciorusso A; Vendemiale G; Serviddio G Free Radic Biol Med; 2017 Oct; 111():173-185. PubMed ID: 28109892 [TBL] [Abstract][Full Text] [Related]
38. fat-1 mice prevent high-fat plus high-sugar diet-induced non-alcoholic fatty liver disease. Guo XF; Gao JL; Li JM; Li D Food Funct; 2017 Nov; 8(11):4053-4061. PubMed ID: 28972610 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of EGFR attenuates fibrosis and stellate cell activation in diet-induced model of nonalcoholic fatty liver disease. Liang D; Chen H; Zhao L; Zhang W; Hu J; Liu Z; Zhong P; Wang W; Wang J; Liang G Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):133-142. PubMed ID: 29038049 [TBL] [Abstract][Full Text] [Related]
40. Considerations When Choosing High-Fat, High-Fructose, and High-Cholesterol Diets to Induce Experimental Nonalcoholic Fatty Liver Disease in Laboratory Animal Models. Radhakrishnan S; Yeung SF; Ke JY; Antunes MM; Pellizzon MA Curr Dev Nutr; 2021 Dec; 5(12):nzab138. PubMed ID: 34993389 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]